This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Chang-Ling Lin: Innovator in Vaccine Development
Introduction
Chang-Ling Lin is a prominent inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of vaccine development, particularly through his innovative methods in preparing and purifying recombinant lipoproteins.
Latest Patents
Chang-Ling Lin holds a patent for a method for preparing and purifying recombinant lipoprotein Ag473 of group B isolates. This method is crucial for the large-scale production of vaccines targeting group B pathogens. His work in this area demonstrates his commitment to advancing public health through scientific innovation.
Career Highlights
Lin is affiliated with the National Health Research Institutes, where he continues to engage in groundbreaking research. His expertise in vaccine technology has positioned him as a key figure in the fight against infectious diseases.
Collaborations
Throughout his career, Chang-Ling Lin has collaborated with notable colleagues, including Shih-Yang Hsieh and Pele Choi-Sing Chong. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Chang-Ling Lin's contributions to vaccine development highlight the importance of innovation in addressing global health challenges. His work exemplifies the role of inventors in advancing medical science and improving public health outcomes.